Clinical Trial

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Study acronym: GA-25
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The present study investigates the postprandial role of endogenous glucose-dependent insulinotropic polypeptide (GIP) on cardiovascular haemodynamics, hormone responses, and hypotensive symptoms during a tilt test.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-11; most recent amendment 2025-09-01.
Status change: Not Yet Recruiting → Recruiting 2025-09-01
Trial Details
NCT Number NCT06934473
Lead Sponsor University Hospital, Gentofte, Copenhagen
Conditions Bloodpressure
Enrollment 16 participants
Start Date 2025-05-21
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08